Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene add-on vs placebo in postmenopausal schizophrenia
2010-023983-42Phase 3Completed
- Sponsor
- Stanley Medical Research Institute
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia and schizoaffective disorder comparing Raloxifene (Evista) add-on with Placebo add-on (2 arms). Primary endpoint: PANSS total score at end of trial. Started Nov 2010; status: completed.
02
Drugs
raloxifene
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on 2010-023983-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023983-42.